Irbesartan and Hydrochlorothiazide
- Product NDC
- 43547-672
- 11-digit product format
- 435470672
- Labeler code
- 43547
- Product ID
- 43547-672_da1c9acf-6323-4ef5-bfff-8eedc7992d78
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Irbesartan and Hydrochlorothiazide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Solco Healthcare US, LLC
- Application
- ANDA203072
- Marketing category
- ANDA
- Marketing start
- 2014-03-01
- Marketing end
- 0000-00-00
- Substance
- HYDROCHLOROTHIAZIDE; IRBESARTAN
- Active strength
- 25 mg/1; mg/1
- Pharmacologic classes
- Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 43547-672-03 | 43547067203 | 30 TABLET in 1 BOTTLE (43547-672-03) | 30 tablet | 2014-03-01 | 0000-00-00 | No | No | Current |
| 43547-672-09 | 43547067209 | 90 TABLET in 1 BOTTLE (43547-672-09) | 90 tablet | 2014-03-01 | 0000-00-00 | No | No | Current |
| 43547-672-50 | 43547067250 | 500 TABLET in 1 BOTTLE (43547-672-50) | 500 tablet | 2014-03-01 | 0000-00-00 | No | No | Current |